Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial
Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.

Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page
- Check5 days agoChange DetectedA newer revision identifier appears on the page, indicating a backend or template update; the study content and user-facing information remain unchanged.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page revision label has been updated from v3.6.0 to v3.6.2, indicating a newer version of the ClinicalTrials.gov study page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study page now indicates recruitment is closed and results have been posted. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the 28-day treatment cycle duration is stated.SummaryDifference6%

- Check33 days agoChange DetectedThe page shows a new revision label (v3.5.5), replacing the previous v3.5.4, signaling a minor backend or template update without changes to study data.SummaryDifference0.0%

- Check40 days agoChange DetectedRemoved the text '2024-01-26' and the label 'Certification/Extension First Posted' from the Study Record Dates section, updating the historical QC entries shown for this study record. This change updates what is visible in the record’s QC history without altering the study data or eligibility.SummaryDifference0.1%

- Check55 days agoChange Detected- The page revision tag was updated from v3.5.3 to v3.5.4, signaling a minor update to the page's underlying versioning. - There are no changes to the visible content or user-facing functionality.SummaryDifference0.0%

Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.